Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$509K Buy
+82,766
New +$687K ﹤0.01% 2513
2025
Q3
Sell
-54,893
Closed -$713K 3553
2025
Q2
$713K Buy
54,893
+4,834
+10% +$72.7K ﹤0.01% 1429
2025
Q1
$1.26M Buy
50,059
+4,250
+9% +$126K 0.01% 1021
2024
Q4
$1.57M Buy
+45,809
New +$2.07M 0.01% 851
2024
Q3
Sell
-13,094
Closed -$787K 3038
2024
Q2
$787K Sell
13,094
-22,540
-63% -$1.29M ﹤0.01% 1116
2024
Q1
$1.84M Buy
+35,634
New +$1.75M 0.01% 602
2023
Q3
Sell
-46,044
Closed -$1.33M 2997
2023
Q2
$1.33M Buy
+46,044
New +$1.02M 0.01% 783

Other funds holding RXST

HRT Financial's RXST Position: Q1 2026 in Review

HRT Financial opened a new position in RxSight (RXST) in Q1 2026: 82,766 shares worth $509K. The stake represents ﹤0.01% of the portfolio and ranks #2513 among its holdings. This is a return to the name: HRT Financial previously reported a position in RXST as recently as Q2 2025.

HRT Financial first reported a position in RXST in Q2 2023 and has held it in 7 quarters since. The position peaked at $1.84M in Q1 2024. 164 funds tracked by Wall St. Rank hold RXST as of Q1 2026.

  • HRT Financial held 82,766 shares of RxSight worth $509K as of Q1 2026.
  • RxSight was a new HRT Financial position in Q1 2026.
  • RxSight made up ﹤0.01% of HRT Financial's portfolio in Q1 2026, its #2513 holding.
  • HRT Financial first reported a position in RxSight in Q2 2023 and has held it in 7 quarters since.
  • HRT Financial's RxSight position peaked at $1.84M in Q1 2024.
  • 164 funds tracked by Wall St. Rank held RxSight as of Q1 2026.

Based on HRT Financial's 13F filing for Q1 2026, filed 14 May 2026.